Guardant Health, Inc. (GH) Stock

Guardant Health, Inc. (GH) is a Healthcare stock trading at $131.80 (as of 2026-06-18), with a market capitalization of $17.20B and a trailing P/E of -38.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Guardant Health provides liquid biopsy-based diagnostic tests and supporting software/data resources for oncology care and research. Its offerings include Guardant360 blood tests and GuardantINFORM, an in-silico platform using clinical-genomic datasets, along with additional test programs and solutions for connecting patient results with relevant clinical trials.

Valuation — source: SEC EDGAR (first-party)
Price$131.80
Market Cap$17.20B
P/E Ratio-38.8
EV / EBITDA-43.7
Price / Book-96.50
Price / Sales16.18
DCF Value (model)$-37.98
DCF Upside vs Price-128.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$982.02M
Net Margin-42.4%
Return on Equity239.2%
Debt / Equity-8.30
Current Ratio4.68
Revenue Growth (YoY)48.3%
EPS Growth (YoY)10.4%
FCF Growth (YoY)6.0%
Financial Health — source: SEC EDGAR
Altman Z-Score3.29 (safe)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-38.8
Sector P/E (Healthcare)21.0
Industry P/E (Healthcare Services)23.0
vs Sector-284.9%
vs Industry-268.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($1.24B)
Institutional Holders Tracked10
Congressional Trades (recent)1
Company
SectorHealthcare
IndustryHealthcare Services
CEOHelmy Eltoukhy
Employees1,999
CountryUS
IPO Date2018-10-04

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Natera, Inc. (NTRA)
  • Labcorp Holdings Inc. (LH)
  • Quest Diagnostics Incorporated (DGX)
  • Medpace Holdings, Inc. (MEDP)
  • ICON Public Limited Company (ICLR)
  • Charles River Laboratories International, Inc. (CRL)
  • Repligen Corporation (RGEN)
  • Caris Life Sciences, Inc. (CAI)
GH earnings history · GH institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.